Universidad San Sebastián  
 

Repositorio Institucional Universidad San Sebastián

Búsqueda avanzada

Descubre información por...

 

Título

Ver títulos
 

Autor

Ver autores
 

Tipo

Ver tipos
 

Materia

Ver materias

Buscar documentos por...




Mostrar el registro sencillo del ítem

dc.contributor.author Augustovski, Federico
dc.contributor.author Colantonio, Lisandro D.
dc.contributor.author Galante, Julieta
dc.contributor.author Bardach, Ariel
dc.contributor.author Caporale, Joaquín E.
dc.contributor.author Zárate, Víctor
dc.contributor.author Chuang, Ling Hsiang
dc.contributor.author Riviere, Andres Pichon
dc.contributor.author Kind, Paul
dc.date.accessioned 2024-09-26T00:41:47Z
dc.date.available 2024-09-26T00:41:47Z
dc.date.issued 2018-02
dc.identifier.issn 2322-5939
dc.identifier.uri https://repositorio.uss.cl/handle/uss/13158
dc.description Publisher Copyright: © 2018 The Author(s).
dc.description.abstract Background: The measurement of health benefits is a key issue in health economic evaluations. There is very scarce empirical literature exploring the differences of using quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs) as benefit metrics and their potential impact in decision-making. Methods: Two previously published models delivering outputs in QALYs, were adapted to estimate DALYs: a Markov model for human papilloma virus (HPV) vaccination, and a pneumococcal vaccination deterministic model (PNEUMO). Argentina, Chile, and the United Kingdom studies were used, where local EQ-5D social value weights were available to provide local QALY weights. A primary study with descriptive vignettes was done (n = 73) to obtain EQ-5D data for all health states included in both models. Several scenario analyses were carried-out to evaluate the relative importance of using different metrics (DALYS or QALYs) to estimate health benefits on these economic evaluations. Results: QALY gains were larger than DALYs avoided in all countries for HPV, leading to more favorable decisions using the former. With discounting and age-weighting – scenario with greatest differences in all countries – incremental DALYs avoided represented the 75%, 68%, and 43% of the QALYs gained in Argentina, Chile, and United Kingdom respectively. Differences using QALYs or DALYs were less consistent and sometimes in the opposite direction for PNEUMO. These differences, similar to other widely used assumptions, could directly influence decision-making using usual gross domestic products (GDPs) per capita per DALY or QALY thresholds. Conclusion: We did not find evidence that contradicts current practice of many researchers and decision-makers of using QALYs or DALYs interchangeably. Differences attributed to the choice of metric could influence final decisions, but similarly to other frequently used assumptions. en
dc.language.iso eng
dc.relation.ispartof vol. 7 Issue: no. 2 Pages: 120-136
dc.source International Journal of Health Policy and Management
dc.title Measuring the benefits of healthcare : DALYs and QALYs – Does the choice of measure matter? A case study of two preventive interventions en
dc.type Artículo
dc.identifier.doi 10.15171/ijhpm.2017.47
dc.publisher.department Facultad de Medicina y Ciencia


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem